Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,241,597
  • Shares Outstanding, K 192,114
  • Annual Sales, $ 2,854 M
  • Annual Income, $ 426,860 K
  • EBIT $ 596 M
  • EBITDA $ 685 M
  • 60-Month Beta 0.30
  • Price/Sales 3.57
  • Price/Cash Flow 16.33
  • Price/Book 1.68

Options Overview Details

View History
  • Implied Volatility 38.28% (+0.86%)
  • Historical Volatility 27.44%
  • IV Percentile 66%
  • IV Rank 40.15%
  • IV High 55.63% on 04/10/25
  • IV Low 26.64% on 03/24/25
  • Expected Move (DTE 4) 2.13 (3.99%)
  • Put/Call Vol Ratio 1.01
  • Today's Volume 843
  • Volume Avg (30-Day) 1,268
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 41,634
  • Open Int (30-Day) 41,063
  • Expected Range 51.19 to 55.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.76
  • Number of Estimates 10
  • High Estimate 1.02
  • Low Estimate 0.66
  • Prior Year 0.72
  • Growth Rate Est. (year over year) +5.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.99 +2.54%
on 11/19/25
56.45 -5.56%
on 11/25/25
-2.01 (-3.63%)
since 11/12/25
3-Month
50.76 +5.02%
on 11/07/25
56.80 -6.14%
on 10/28/25
-0.78 (-1.44%)
since 09/12/25
52-Week
50.76 +5.02%
on 11/07/25
73.51 -27.48%
on 03/07/25
-12.95 (-19.54%)
since 12/12/24

Most Recent Stories

More News
2 Reasons to Like BMRN and 1 to Stay Skeptical

2 Reasons to Like BMRN and 1 to Stay Skeptical

BMRN : 53.31 (+0.60%)
Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

BMRN : 53.31 (+0.60%)
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

ABT : 125.46 (+1.77%)
BMRN : 53.31 (+0.60%)
ABBV : 223.32 (-0.29%)
DXCM : 66.96 (-2.87%)
BIIB : 174.10 (+0.93%)
BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?

BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?

BMRN : 53.31 (+0.60%)
1 Safe-and-Steady Stock on Our Watchlist and 2 We Question

1 Safe-and-Steady Stock on Our Watchlist and 2 We Question

SBGI : 16.45 (-3.24%)
BMRN : 53.31 (+0.60%)
BGS : 4.78 (-1.24%)
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

OSCR : 16.63 (+4.79%)
VTRS : 11.65 (+0.52%)
BMRN : 53.31 (+0.60%)
BLCO : 16.99 (-1.62%)
QDEL : 28.80 (-2.90%)
BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

SAN RAFAEL, Calif. , Nov. 11, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday,...

BMRN : 53.31 (+0.60%)
3 Cash-Producing Stocks with Promising Prospects

3 Cash-Producing Stocks with Promising Prospects

AXON : 564.28 (-2.88%)
BMRN : 53.31 (+0.60%)
CPNG : 25.63 (-0.89%)
The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call

BMRN : 53.31 (+0.60%)
FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet alone

BMRN : 53.31 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 54.32
2nd Resistance Point 53.83
1st Resistance Point 53.57
Last Price 53.31
1st Support Level 52.81
2nd Support Level 52.32
3rd Support Level 52.06

See More

52-Week High 73.51
Fibonacci 61.8% 64.82
Fibonacci 50% 62.14
Fibonacci 38.2% 59.45
Last Price 53.31
52-Week Low 50.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar